Drawing for PROJECH SCIENCE TO TECHNOLOGY

USPTO serial 79070131

PROJECH SCIENCE TO TECHNOLOGY

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
KAJUBI, ELIZABETH N
Law office
TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PROJECH SCIENCE TO TECHNOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Stem cells for medical purposes; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophtalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological bone tissue intended for subsequent implantation, biological skin tissue intended for subsequent implantation, biological kidney tissue intended for subsequent implantation, biological liver tissue intended for subsequent implantation, biological neural tissue intended for subsequent implantation, biological lung tissue intended for subsequent implantation, biological cardiac tissue intended for subsequent implantation, biological dental tissue intended for subsequent implantation, biological muscle tissue intended for subsequent implantation, biological digestive tissue intended for subsequent implantation, biological reproductive tissue intended for subsequent implantationSECTION 70 - CANCELLED—
042Computer programming in the medical field; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics and phamacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the fields of genomics, cytomics, proteomics and biotechnology; medical and scientific research in the field of genomics, cytomics, proteomics and biotechnology; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trialsSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 21, 2019DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Dec 20, 2019DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 27, 2012NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 17, 2011FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 25, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 25, 2011FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 15, 2011OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 23, 2010OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 23, 2010OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 25, 2010MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 25, 2010ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 29, 2009RFNTREFUSAL PROCESSED BY IB—
Aug 27, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 27, 2009RFRRREFUSAL PROCESSED BY MPU—
Aug 27, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 26, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 19, 2009DOCKASSIGNED TO EXAMINER—
Jul 28, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 24, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 23, 2009LIMSLIMITATION OF GOODS/SERVICES FROM IB ENTERED—
Jul 23, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance